VAXCYTE INC (PCVX:NASDAQ)
$61.98 -0.22 (-0.3537%)
Analysed VAXCYTE INC (PCVX:NASDAQ) News Sources
Is It Too Late To Consider Vaxcyte (PCVX) After A 95% One-Year Share Price Jump?
11-04-2026
yahoo.com
Vaxcyte to Present at the 25th Annual Needham Virtual Healthcare Conference
07-04-2026
yahoo.com
Vaxcyte Completes Enrollment of OPUS-1 and OPUS-2 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults
23-03-2026
yahoo.com
High-Flying Biotech Stock Up 360% Faces $48 Million Trim but Remains This Fund's Largest Holding
21-03-2026
fool.com
Positive VAX-31 Phase 1/2 Adult Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcyte’s 31-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate
18-03-2026
yahoo.com
Does Heavy 2025 Loss and Large Equity Raise for Vaxcyte’s VAX-31 Shift the Bull Case (PCVX)?
02-03-2026
yahoo.com
Love A Little Risk? Wall Street Sees Massive Upside in Vaxcyte Stock.
02-03-2026
barchart.com
Vaxcyte Advances VAX-31 Toward Phase 3 As Valuation Gap Persists
02-03-2026
yahoo.com
A Look At Vaxcyte (PCVX) Valuation As Share Price Momentum Rebuilds
02-03-2026
yahoo.com
Vaxcyte, Inc. Q4 2025 Earnings Call Summary
25-02-2026
moby.co
What is the current price of VAXCYTE INC (PCVX:NASDAQ)?
The current price of VAXCYTE INC (PCVX:NASDAQ) is $61.98.
VAXCYTE INC (PCVX:NASDAQ) absolute price change since previous trading day?
The absolute price change of VAXCYTE INC (PCVX:NASDAQ) since the previous trading day is $-0.22.
VAXCYTE INC (PCVX:NASDAQ) percentage price change since previous trading day?
The percentage price change of VAXCYTE INC (PCVX:NASDAQ) since the previous trading day is -0.3537%.
What is the most recent average sentiment score for VAXCYTE INC (PCVX:NASDAQ)?
The most recent average sentiment score for VAXCYTE INC (PCVX:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for VAXCYTE INC (PCVX:NASDAQ)?
The most recent sentiment for VAXCYTE INC (PCVX:NASDAQ) is .
SEC-8K** Filing Available For VAXCYTE INC (PCVX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.